Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus
Clinical trial NCT01072331 · COMPLETED
Trial details
- NCT number
- NCT01072331
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-08-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.